Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC.

Journal article

Göttgens E-L. et al, (2020), Radiother Oncol, 149, 1 - 7

Hypoxia-activated pro-drugs of the KDAC inhibitor vorinostat (SAHA)

Journal article

Calder EDD. et al, (2020), Tetrahedron, 76

A New Assay to Measure Intestinal Crypt Survival after Irradiation: Challenges and Opportunities.

Journal article

Muschel RJ. et al, (2020), Cancer Res, 80, 927 - 928

Meeting report on ICRR2019, the 16th International Congress on Radiation Research.

Journal article

Williams KJ. et al, (2020), Int J Radiat Biol, 96, 167 - 171

Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

Journal article

Wilson JD. et al, (2020), Front Oncol, 10

Targeting tumor hypoxia

Chapter

Skwarski M. et al, (2020), Cancer Drug Discovery and Development, 265 - 299

Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas.

Journal article

Göttgens E-L. et al, (2019), Int J Radiat Oncol Biol Phys, 105, 548 - 558

CDK4/CDK6 inhibition radiosensitises HPV-neg HNSCC through inhibition of homologous recombination

Journal article

Gottgens E. et al, (2019), RADIOTHERAPY AND ONCOLOGY, 133, S129 - S130

HPV, hypoxia and radiation response in head and neck cancer.

Journal article

Göttgens E-L. et al, (2019), Br J Radiol, 92

Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

Journal article

Wilson JD. et al, (2019), Front Oncol, 9

Hypoxia-Activated, Small-Molecule-Induced Gene Expression.

Journal article

Collins SL. et al, (2018), ACS Chem Biol, 13, 3354 - 3360

Load More